Quant corner looks at Biotech
Article Abstract:
Biotechnological firms have increased their insider trading volume in anticipation of future revenues. Many firms in this sector lack capital resources and are thus in the market for long-term profits. The Signal II model predicts that such firms generally reap sizeable earnings around six months to a year from the release of its recommendations. Among the more notable firms in this category are AutoImmune and Alkermes.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
Largest insider trades
Article Abstract:
Statistics on the 30 largest insider trades in the United States are presented. The chart includes information on the company name, the number of insiders, the number of shares traded and their corresponding value. The largest insider purchases are led by Peoplesoft Inc., Discount Auto Parts Inc. and Medical Resources Inc. On the other hand, the largest insider sales are led by ACC Corp. and Mattel Inc.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1996
User Contributions:
Comment about this article or add new information about this topic:
Biotech ... after the rally
Article Abstract:
Many biotechnology industry insiders are still optimistic about the future of biotechnology stocks. Among the companies expected to post significant increases in stock prices are Targeted Genetics, Biocryst Pharmaceuticals, Cortech Inc., Penederm Inc. Nexstar Pharmaceuticals and Sangstat Medical Corp. Based on insider quantitative models, the stocks of these companies will appreciate considerably.
Publication Name: CDA-Investnet Insiders' Chronicle
Subject: Business
ISSN: 1074-0139
Year: 1995
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Indian companies see increasing capital expenditure. After the Orange Revolution. Euro Disney pins its hopes on refinancing
- Abstracts: The non-practitioner's view. Chartered: the premium brand. Where members' money goes
- Abstracts: Clearer picture. Beyond the Berlin wall
- Abstracts: Take three corporate bond Peps.... Man's best friend? Advice for bond pep buyers
- Abstracts: Facelift for Ferruzzi. Ship with no rudder. Power struggle